Report of Foreign Issuer (6-k)
November 02 2017 - 6:56AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2017
Commission File Number: 001-37891
AC IMMUNE SA
(Exact name of registrant as specified
in its charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address
of principal executive office)
Indicate by
check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by
check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
AC IMMUNE SA
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Andrea Pfeifer
|
|
|
|
|
Name:
|
Andrea Pfeifer
|
|
|
|
|
Title:
|
Chief Executive Officer
|
|
|
|
|
|
|
By:
|
/s/ Joerg Hornstein
|
|
|
|
|
Name:
|
Joerg Hornstein
|
|
|
|
|
Title:
|
Chief Financial Officer
|
Date:
November 2, 2017
EXHIBIT
INDEX
Exhibit Number
|
Description
|
99.1
|
Press Release dated November 2, 2017
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Aug 2024 to Sep 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Sep 2023 to Sep 2024